Verified earnings results

Arcturus Therapeutics Holdings Q3 2026 Earnings Results

Direct answer

Arcturus Therapeutics Holdings reported Q3 2026 results on November 5, 2026.

Revenue was 18,297,000. EPS beat the estimate by 62.44%.
The result is verified against Verified earnings source.
Verified earnings source

Get free Arcturus Therapeutics Holdings email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Earnings date
November 5, 2026
Reported timing
After the US market closes
EPS estimate
-0.6923
Reported EPS
-0.26
Revenue
18,297,000
EPS surprise
EPS beat the estimate by 62.44%.

Read the frequently asked questions.

When did Arcturus Therapeutics Holdings report Q3 2026 earnings?

Arcturus Therapeutics Holdings reported on November 5, 2026. The reported timing was after the us market closes.

What is the available EPS estimate for Arcturus Therapeutics Holdings?

The verified record provides an EPS estimate of -0.6923.

Has Arcturus Therapeutics Holdings reported the Q3 2026 result?

Revenue was 18,297,000. EPS beat the estimate by 62.44%.

Which source supports this Arcturus Therapeutics Holdings earnings record?

The earnings record identifies Verified earnings source as its source. Missing values are not estimated.